Delivery Order SPE2DB20D3303-SPE2DB25FA3BF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Advair HFA 115-21 micrograms inhalers (12-gram units) with a ceiling value of $2,208.80. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $16,867.50 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12-gram units) with a contract ceiling value of $6,737.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.09 to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12-gram units). This is a firm fixed-price, non-set-aside contract with a completion date of June 27, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $3,379.68. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by November 5, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) with a ceiling value of $2,162.26. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Advair HFA 230-21 mcg inhalers in 12-gram units. This non-set-aside, competitively awarded contract carries a ceiling value of $2,184.26 and is structured as a firm fixed price delivery order with an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a $2,965.10 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery...
- The Defense Logistics Agency awarded a $3,092.18 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams) with a completion date of September 15, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award through open solicitation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3BFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams) with a ceiling value of $1,108.14. This is a firm fixed price delivery order with no set-aside designation, completed competitively on an open basis. The contract is set to conclude on August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's broader federal contract relationship with the Defense Logistics Agency. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive contract portfolio with the DLA encompasses a wide range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains, enabling the company to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/28/25 |